Fluticasone-salmeterol combination does not cause more serious asthma-related events than fluticasone in moderate-to-severe asthma, indicated a study. Routine use of short-acting beta blockers like ...
Objective: To compare the efficacy and tolerability of a salmeterol/fluticasone propionate (FP) combination product (50/100µg twice daily) with budesonide (BUD) at a four-fold higher microgram dose ...
I have a few questions about fluticasone-salmeterol. Is it true that the current guidelines call for dual therapy as opposed to monotherapy, ie, inhaled steroids? Also, if a child has recurrent use of ...
asthma The risk of serious asthma-related events was no greater with the combination of long-acting beta-agonist (LABA) salmeterol + the inhaled glucocorticoid, fluticasone propionate, versus ...
Initiation of fluticasone propionate–salmeterol after a COPD-related hospitalization or ED visit decreased the risk of a recurrent event and reduced COPD-related medical costs. Objectives: To quantify ...
Review the side-effects of Salmeterol and Fluticasone as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In ...
The mean proportion of days covered in the fluticasone furoate/vilanterol group was significantly higher than in the budesonide/formoterol and fluticasone propionate/salmeterol groups. SEATTLE — ...
Efficacy trials suggest that extra-fine particle beclometasone dipropionate-formoterol (efBDP-FOR) is comparable to fluticasone propionate-salmeterol (FP-SAL) in preventing asthma exacerbations at a ...
This cost-utility analysis compares the cost-effectiveness of salmeterol, fluticasone propionate, combination salmeterolfluticasone, and no maintenance therapy in chronic obstructive pulmonary disease ...
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Serious ...
TEL AVIV, ISRAEL & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Respiratory, LLC., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the launch of AirDuo ® ...
Please provide your email address to receive an email when new articles are posted on . Fluticasone-based inhaled corticosteroid treatment substantially changed airway microbiome diversity in patients ...